Roll over image to zoom in
Natdac (DAKLINZA) Daclatasvir 60mg online
$27.00
Status: In stock
An NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic hepatitis C virus genotype 1 or 3 infection.
Natdac (Daclatasvir 60mg)is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use:
1.Sustainedvirologicresponse(SVR12)ratesarereducedingenotype3patientswith cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
1.Sustainedvirologicresponse(SVR12)ratesarereducedingenotype3patientswith cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
Related products
Recently Viewed Products
